{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:20:03Z","timestamp":1793064003520,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG058676"],"award-info":[{"award-number":["R01 AG058676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neurobiolaging.2025.12.006","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:05:28Z","timestamp":1766189128000},"page":"22-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Regional growth rates of white matter hyperintensities are associated with beta-amyloid burden"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8381-8646","authenticated-orcid":false,"given":"Jeremy F.","family":"Strain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Phuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Dierker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei G.","family":"Vlassenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierreck","family":"Bourgeat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Fripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Moulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Womack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu S.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.12.006_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1179\/016164104225016272","article-title":"The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease","volume":"26","author":"Bailey","year":"2004","journal-title":"Neurol. Res"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.12.006_bib2","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/alz.13765","article-title":"Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: a multicenter study in 3132 memory clinic patients","volume":"20","author":"Biesbroek","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119527","article-title":"beta-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3","volume":"262","author":"Bourgeat","year":"2022","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2014.07.019","article-title":"Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence","volume":"36","author":"Brickman","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.12.006_bib5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/jnnp-2021-326569","article-title":"Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta-analysis with implications for clinical trial design","volume":"92","author":"Brown","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.12.006_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib7","doi-asserted-by":"crossref","unstructured":"Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., Jr, Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T., Jr., Roccella, E.J., National Heart, L.., Blood Institute Joint National Committee on Prevention, D.E., Treatment of High Blood, P., National High Blood Pressure Education Program Coordinating, C., 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289(19), 2560-2572. doi: 10.1161\/01.HYP.0000107251.49515.c2.","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.12.006_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrn1788","article-title":"Axon degeneration mechanisms: commonality amid diversity","volume":"6","author":"Coleman","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib9","first-page":"83","article-title":"Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity","volume":"2","author":"Collins-Praino","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib10","article-title":"The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition","volume":"12","author":"Dadar","year":"2020","journal-title":"Alzheimers Dement (Amst. )"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.12.006_bib11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/mdc3.13073","article-title":"Reply to: cerebral vasomotor reactivity in parkinson's disease: a missing link between dysautonomia, white matter lesions, and cognitive decline?","volume":"7","author":"Dadar","year":"2020","journal-title":"Mov. Disord. Clin. Pr."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.12.006_bib12","doi-asserted-by":"crossref","first-page":"e1168","DOI":"10.1212\/WNL.0000000000007093","article-title":"Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics","volume":"92","author":"de Havenon","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1474-4422(23)00449-0","article-title":"Dementia research in 2023: the year of anti-amyloid immunotherapy","volume":"23","author":"Delrieu","year":"2024","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1567205010666131119234845","article-title":"Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease","volume":"11","author":"den Abeelen","year":"2014","journal-title":"Curr. Alzheimer Res"},{"issue":"7964","key":"10.1016\/j.neurobiolaging.2025.12.006_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","article-title":"Myelin dysfunction drives amyloid-beta deposition in models of Alzheimer's disease","volume":"618","author":"Depp","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.12.006_bib16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2353\/ajpath.2010.100087","article-title":"Early oligodendrocyte\/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target","volume":"177","author":"Desai","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13195-021-00869-6","article-title":"White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease","volume":"13","author":"Desmarais","year":"2021","journal-title":"Alzheimers Res Ther."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.12.006_bib18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/CIRCULATIONAHA.115.021275","article-title":"Revised Framingham stroke risk profile to reflect temporal trends","volume":"135","author":"Dufouil","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13402","article-title":"White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS)","author":"Eloyan","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.12.006_bib20","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1002\/alz.13057","article-title":"White matter hyperintensities in Alzheimer's disease: beyond vascular contribution","volume":"19","author":"Garnier\u2010Crussard","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.12.006_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2212256120","article-title":"Brain aerobic glycolysis and resilience in Alzheimer disease","volume":"120","author":"Goyal","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.12.006_bib22","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/brain\/awz162","article-title":"White matter hyperintensities: relationship to amyloid and tau burden","volume":"142","author":"Graff-Radford","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.12.006_bib24","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.neurobiolaging.2012.01.016","article-title":"White matter hyperintensities predict amyloid increase in Alzheimer's disease","volume":"33","author":"Grimmer","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib25","article-title":"Periventricular and deep white matter hyperintensity thresholds in aging: exponential progression","author":"Gupta","year":"2024","journal-title":"Cogn. Decline Neuroanat. Atrophy. bioRxiv 2024. 2009. 2003. 610993"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/alz.12178","article-title":"The Brain Chart of Aging: machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans","volume":"17","author":"Habes","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archneur.1987.00520130013009","article-title":"Leuko-araiosis","volume":"44","author":"Hachinski","year":"1987","journal-title":"Arch. Neurol."},{"issue":"50","key":"10.1016\/j.neurobiolaging.2025.12.006_bib28","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1523\/JNEUROSCI.4686-08.2008","article-title":"Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition","volume":"28","author":"Han","year":"2008","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.12.006_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.neurobiolaging.2010.05.007","article-title":"Amyloid beta1-42 oligomer inhibits myelin sheet formation in vitro","volume":"33","author":"Horiuchi","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.12.006_bib30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/00001756-200308060-00005","article-title":"Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo","volume":"14","author":"Jantaratnotai","year":"2003","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.12.006_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","article-title":"A global optimisation method for robust affine registration of brain images","volume":"5","author":"Jenkinson","year":"2001","journal-title":"Med Image Anal."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.12.006_bib32","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/alz.13729","article-title":"Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage","volume":"20","author":"Joseph-Mathurin","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.dadm.2016.03.001","article-title":"White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration","volume":"4","author":"Kandel","year":"2016","journal-title":"Alzheimers Dement (Amst."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.12.006_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jnen\/nlx009","article-title":"Collagenosis of the Deep Medullary Veins: An Underrecognized Pathologic Correlate of White Matter Hyperintensities and Periventricular Infarction?","volume":"76","author":"Keith","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.12.006_bib35","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/jch.14030","article-title":"Effect of intensive blood pressure control on the prevention of white matter hyperintensity: systematic review and meta-analysis of randomized trials","volume":"22","author":"Lai","year":"2020","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.12.006_bib36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","article-title":"White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network","volume":"79","author":"Lee","year":"2016","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.54.1.46","article-title":"Could Wallerian degeneration contribute to \"leuko-araiosis\" in subjects free of any vascular disorder?","volume":"54","author":"Leys","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/17474930221144911","article-title":"Cerebral small vessel disease: recent advances and future directions","volume":"18","author":"Markus","year":"2023","journal-title":"Int J. Stroke"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40478-015-0240-0","article-title":"Cortical tau load is associated with white matter hyperintensities","volume":"3","author":"McAleese","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.12.006_bib40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00401-021-02376-2","article-title":"Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology","volume":"142","author":"McAleese","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.12.006_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-017-1738-2","article-title":"Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease","volume":"134","author":"McAleese","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.12.006_bib42","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116944","article-title":"White matter hyperintensities are associated with subthreshold amyloid accumulation","volume":"218","author":"Moscoso","year":"2020","journal-title":"Neuroimage"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.12.006_bib44","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/NEN.0b013e318277387e","article-title":"A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology","volume":"71","author":"Murray","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"23","key":"10.1016\/j.neurobiolaging.2025.12.006_bib45","doi-asserted-by":"crossref","first-page":"e2535","DOI":"10.1212\/WNL.0000000000201186","article-title":"Association of data-driven white matter hyperintensity spatial signatures with distinct cerebral small vessel disease etiologies","volume":"99","author":"Phuah","year":"2022","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.12.006_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.1055","article-title":"Association of intensive vs standard blood pressure control with regional changes in cerebral small vessel disease biomarkers: post hoc secondary analysis of the SPRINT MIND randomized clinical trial","volume":"6","author":"Rashid","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"37","key":"10.1016\/j.neurobiolaging.2025.12.006_bib47","doi-asserted-by":"crossref","first-page":"11080","DOI":"10.1021\/bi026173d","article-title":"Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease","volume":"41","author":"Roher","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib48","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2023.3618","article-title":"Etiology of white matter hyperintensities in autosomal dominant and sporadic Alzheimer disease","author":"Shirzadi","year":"2023","journal-title":"JAMA Neurol."},{"issue":"5713","key":"10.1016\/j.neurobiolaging.2025.12.006_bib49","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib50","article-title":"Accuracy of TrUE-Net in comparison to established white matter hyperintensity segmentation methods: an independent validation study","volume":"285","author":"Strain","year":"2023","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2021.102184","article-title":"Triplanar ensemble U-Net model for white matter hyperintensities segmentation on MR images","volume":"73","author":"Sundaresan","year":"2021","journal-title":"Med Image Anal."},{"key":"10.1016\/j.neurobiolaging.2025.12.006_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101952","article-title":"The cross-sectional association between amyloid burden and white matter hyperintensities in older adults without cognitive impairment: a systematic review and meta-analysis","volume":"88","author":"Twait","year":"2023","journal-title":"Ageing Res Rev."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.12.006_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.12.006_bib54","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.12.006_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neurobiolaging.2010.02.005","article-title":"Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease","volume":"33","author":"Yezhuvath","year":"2012","journal-title":"Neurobiol. Aging"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:13:22Z","timestamp":1773947602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458025002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":55,"alternative-id":["S0197458025002180"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.12.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional growth rates of white matter hyperintensities are associated with beta-amyloid burden","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}